OPRX News and Press, OptimizeRx Corporation From 04/26/24

1Q24 revenue expected to grow over 40% year-over-year and come in between $18.5 - $19.2 million First quarter revenue and adjusted EBITDA to come in ahead of consensus DAAP adoption and cross selling activities are tracking ahead of internal expectations WALTHAM, Mass...

WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, has published its Environment...

2024-04-16 07:06:19 ET More on OptimizeRx OptimizeRx Corporation (OPRX) Q4 2023 Earnings Call Transcript OptimizeRx: Exponential Growth Drives The Valuation Cheaper OptimizeRx Q4 2023 Earnings Preview OptimizeRx provides update on the timing of earnings call ...

Q4 revenue of $28.4 million, increasing 44% year-over-year Q4 gross profit increased 43% year-over-year to $17.8 million with gross margins coming in at 63% for both periods Acquired Healthy Offers, Inc. (dba Medicx Health), a leading healthcare consumer-focused omnichannel marketing and ...

2024-04-13 17:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

WALTHAM, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, has secured a coveted sp...

2024-04-06 06:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you’re looking for undervalued stocks , you don’t have to look far, despite the rally. The past year or so has been a wild rollercoaster ride for investors. While the major...

2024-04-03 19:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-01 15:15:02 ET RBC Capital analyst issues BUY recommendation for OPRX on April 1, 2024 02:00PM ET. The previous analyst recommendation was Buy. OPRX was trading at $11.525 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...

2024-03-28 14:10:26 ET More on OptimizeRx OptimizeRx Corporation (OPRX) Q4 2023 Earnings Call Transcript OptimizeRx: Exponential Growth Drives The Valuation Cheaper Read the full article on Seeking Alpha For further details see: OptimizeRx Q4 revenue $28.4M